Saventaro Cat's Claw
Withdrawn from the US market on 11 August 2023 (according to the DSLD)
Enzymatic Therapy, food supplement from the US market
Label withdrawn from the US market. Saventaro Cat's Claw (Enzymatic Therapy), a food supplement au code-barres 763948098538, is described by its US market label. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Enzymatic Therapy
- Barcode
- 763948098538
- Form
- Capsule
- One serving
- 1 capsule
- Servings
- up to 3 servings per day
- Other ingredients (in English, as written)
- Cellulose, plant-derived Capsule, Calcium Carbonate, Magnesium Stearate, Silicon Dioxide
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Saventaro POA Cat's Claw (Pentacyclic chemotype) root extract | Plant | 20 mg |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Saventaro Max-Strength Cat's Claw
Entered into DSLD on 25 September 2013. Withdrawn from the US market on 12 June 2017 (according to the DSLD).- Same quantity, different name: POA Cat's Claw (pentacyclic chemotype) (Saventaro brand) root extract in this version; Saventaro POA Cat's Claw (Pentacyclic chemotype) root extract on the displayed label (20 mg)
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Enzymatic Therapy
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Saventaro Cat's Claw : étiquette retirée du marché américain (Enzymatic Therapy): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/763948098538-saventaro-cat-s-claw-enzymatic-therapy, updated 11 August 2023.